Experiment Bank - The site for free exchange, review, and discussion of novel scientific experiments Front Page ? Everything ? News ? Wish list ? Help ? FAQ
?Indirect targeting of an elevated GTPase in ovarian cancer

genomics
By Aina, Section Biology
Posted on Fri Apr 30th, 2010 at 10:36:01 PM PST
Ovarian cancer is the leading cause of cancer death among gynecological malignancies, and it ranks as the fifth most frequent cause of cancer death in women. Elevated expression of Rab25 has been associated with ovarian cancer pathogenesis. Rab proteins are Ras-like small GTPases that are activated and deactivated dependent on their GTP- and GDP-bound form. The conversion between the two forms is orchestrated by various factors, including GDF (GDI displacement factor). Identification of the Rab25 associated GDF could provide a target for inhibition of growth of human epithelial ovarian cancer cells.

So I propose an experiment to examine all protein-protein interactions that involves Rab25 in order to identify the Rab25 associated GDF. Other Rab associated GDF have already been identified, and their sequence will be used in order to look for sequence homolgy in our protein-protein interaction hits (yeast two-hybrid screen). Candidate Rab25 associated GDF will be tested for function in a nucleotide exchange assay, to confirm that they actually function as a GDF and enable the release of GDP-bound Rab25 so that it is in its free form where it is able to convert to active GTP-bound Rab25.  

The next step will then be to target this Rab25 associated GDF through RNAi in order to knock it down. One can study the effect this will have on inhibiting tumor growth in human epithelial ovarian cancer cells by applying it on ovarian cancer cell lines.

Hopefully this will lead to an inhibition of tumor growth, and one will have managed to identify a novel form of approach to ovarian cancer therapy that might improve patient management.

Stenmark, H. (2009) Rab GTPases as coordinators of vesicle traffic. Nature Reviews, Molecular Cell Biology, 10; 513-523.

Cheng, K.W., Lahad, J.P., Kuo, W., Lapuk, A., Yamada, K., Auersperg, N., Liu, J., Smith-McCune, K., Lu, K.H., Fishman, D., Gray, J.W., and Mills, G.B. (2004) The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers, Nature Medicine, 10,11; 1251-1256.

Dirac-Svejstrup, A.B., Sumizawa, T., and Pfeffer, S.R. (1997) Identification of a GDI displacement factor that releases endosomal Rab GTPases from Rab-GDI. The EMBO Journal, 16, 3; 465-472.

 

< Systems Biology Approach to Identifying Biomarkers for Predict Sensitivity to Cancer Drugs (1 comments) | Alternate Interactomes (1 comments) >



View: Display: Sort:
Indirect targeting of an elevated GTPase in ovarian cancer | 4 comments (4 topical, 0 editorial)
[new] any other experiments? (none / 0) (#1)
by smile on Wed Apr 28th, 2010 at 09:56:50 PM PST
(User Info)

I have a few questions as below: Can a GDF bind to more than one Rab proteins? Are their binding specific? How many GDFs have been discovered? For me, yeast two hybrid might not be the perfect solution for finding Rab-25 specific GDF. Cause as we all know, we will get lots of false positive and negative result from yeast two hybrid. Also, it is labor intensive for the usage of finding a specific protein. Do you have any other experiments that could replace yeast two hybrid? or do you think yeast two hybrid will serve this purpose well?



[new] Replications (none / 0) (#2)
by xerro five on Thu Apr 29th, 2010 at 09:30:03 AM PST
(User Info)

I think you could get around the problems associated with one method by employing others as well. As far as I know, among the multitude of interaction prediction assays, none really stand out as being far above the others in terms of error rates and theoretical problems. So then if you used the Y2H system, co-IP, and maybe an enzymatic method then you could increase the significance of a result by replication. You wouldn't necessarily have to use all of them for the whole experiment either; you could use the other methods to validate candidates. There may even be a possibility for computational prediction of interactions (based on putative binding sites for example) that could narrow the search beforehand.

[ Parent ]


[new] Clarifications (none / 0) (#3)
by timothy auyeung on Thu Apr 29th, 2010 at 01:45:42 PM PST
(User Info)

This is an interesting experiment but I am slightly confused about the greater objectives.

Since the intention behind the proposed experiment is to ultimately silence the functions of Rab25 via knocking down GDI, why not just simply knockdown Rab25 (which I think was already performed by Cheng et al. 2004)? Is it because there may be other Rab proteins that may compensate the loss of Rab25 such that knocking down GDI will functionally silence all the GDI-dependent Rab proteins? Or is the intention to discover additional drug targets besides Rab25?



[new] Another possible method (none / 0) (#4)
by kjs86 on Thu Apr 29th, 2010 at 05:02:04 PM PST
(User Info)

Maybe you could used a proteomics method such as SILAC (or some other quantitative mass spectrometry study) or a 3D gel electrophoresis set-up to look at the phosphorylation states (a phosphate group is exchanged, isn't it? Sorry if not!)?



Indirect targeting of an elevated GTPase in ovarian cancer | 4 comments (4 topical, 0 editorial)
View: Display: Sort:
?+?Menu
? create account
? faq
? search

?+?Login
Make a new account
Username:
Password:

?+?Related Links
? More on genomics
? Also by Aina

BC Cancer Agency Genome Sequence Centre SourceForge Logo Powered by Scoop
All trademarks and copyrights on this page are owned by their respective companies. Comments are owned by the Poster. The Rest ? 1999 The Management

create account | faq | search